Metide TZ 250mg/31.25mg Injection
Marketer
Amon Biotech
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Metide TZ 250mg/31.25mg Injection
Tazicef 250mg/31.25mg injectable solution is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting microbial proliferation, thereby curbing infection spread. Administration must always be overseen by a medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial; prematurely halting treatment can compromise its effectiveness. Complete the entire course, even with symptom improvement. Typical mild side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects warrant immediate medical attention. Allergic reactions (skin rashes, itching, edema, respiratory distress) necessitate prompt emergency care. Inform your physician of all current medications, including over-the-counter drugs, before commencing treatment. Expectant and nursing mothers require medical consultation prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operation of vehicles if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and sufficient hydration are vital for optimal recovery. Your doctor may order blood tests and other investigations to monitor treatment efficacy.
Primary Ingredients of Metide TZ 250mg/31.25mg Injection
No text provided to rephrase.
Uses of Metide TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Metide TZ 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Metide TZ 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Metide TZ 250mg/31.25mg Injection:
The medication will be administered by your physician or their qualified assistant; self-medication is strongly discouraged.
How Metide TZ 250mg/31.25mg Injection works:
Each vial of Metide TZ Injection (250mg/31.25mg) contains ceftazidime, a broad-spectrum antibiotic, and tazobactam, a beta-lactamase inhibitor. Ceftazidime's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial growth and survival. Tazobactam's role is to counteract bacterial resistance mechanisms, thereby bolstering ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Metide TZ 250mg/31.25mg Injection may be used concomitantly with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Metide TZ 250mg/31.25mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Metide TZ 250mg/31.25mg injections are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
The administration of Metide TZ 250mg/31.25mg Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if such effects manifest.
KidneyCAUTION
The injectable formulation of Metide TZ (250mg/31.25mg) requires careful administration in individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
The use of Metide TZ 250mg/31.25mg Injection requires careful consideration in individuals suffering from significant hepatic impairment. Dosage modification of Metide TZ 250mg/31.25mg Injection might be necessary. Medical advice is recommended.
What if you forget to take Metide TZ 250mg/31.25mg Injection :
Should you forget a dose of Metide TZ 250mg/31.25mg Injection, seek advice from your physician.
Facts to Know About Metide TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently